TMEXPLORE Trademark

Trademark Overview


On Thursday, October 1, 2020, a trademark application was filed for TMEXPLORE with the United States Patent and Trademark Office. The USPTO has given the TMEXPLORE trademark a serial number of 79299814. The federal status of this trademark filing is REGISTERED as of Tuesday, September 14, 2021. This trademark is owned by HalioDx. The TMEXPLORE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical analysis services relating to the clinical diagnostic and ongoing evaluation, analysis and study of a cancer or tumor microenvironment; medical assistance; health services namely health assessment services; pharmaceutical compound evaluation services; therapeutic services in the field of oncology diagnosis; medical diagnostics, diagnostics in the field of medicine; genetic and/or tissue analysis services for medical purposes; medical testing services for diagnostic or treatment purposes; medical services for the detection, qualification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis

Research, development, technical design and scientific testing services in the field of oncology; research and development of new products for third parties in the pharmaceutical field; industrial analysis and research services in the field of oncology; biomarker analysis services for pharmaceutical research purposes; microbiological testing services for medical and scientific research; testing biomarkers for clinical trials; tests in laboratories namely testing of cancer related biomarkers; laboratory research services concerning pharmaceutical products; development of testing methods namely development of testing specifications and procedures for the characterization of tumors and tumor microenvironment; research, development, technical design, testing, analysis services and consultation services related thereto in the fields of immunology and oncology; Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research s...
tmexplore

General Information


Serial Number79299814
Word MarkTMEXPLORE
Filing DateThursday, October 1, 2020
Status700 - REGISTERED
Status DateTuesday, September 14, 2021
Registration Number6481164
Registration DateTuesday, September 14, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements


Pseudo MarkTM EXPLORE
Goods and ServicesMedical analysis services relating to the clinical diagnostic and ongoing evaluation, analysis and study of a cancer or tumor microenvironment; medical assistance; health services namely health assessment services; pharmaceutical compound evaluation services; therapeutic services in the field of oncology diagnosis; medical diagnostics, diagnostics in the field of medicine; genetic and/or tissue analysis services for medical purposes; medical testing services for diagnostic or treatment purposes; medical services for the detection, qualification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis
Goods and ServicesResearch, development, technical design and scientific testing services in the field of oncology; research and development of new products for third parties in the pharmaceutical field; industrial analysis and research services in the field of oncology; biomarker analysis services for pharmaceutical research purposes; microbiological testing services for medical and scientific research; testing biomarkers for clinical trials; tests in laboratories namely testing of cancer related biomarkers; laboratory research services concerning pharmaceutical products; development of testing methods namely development of testing specifications and procedures for the characterization of tumors and tumor microenvironment; research, development, technical design, testing, analysis services and consultation services related thereto in the fields of immunology and oncology; Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the fields of biomarker analysis, immune repertoire analysis, tissue and genome analysis; design and development of software in the field of biology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 14, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 14, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeracyte
Party Type30 - Original Registrant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameHalioDx
Party Type20 - Owner at Publication
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Party NameHalioDx
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Sunday, April 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 4, 2022GENERIC MADRID TRANSACTION SENT TO IB
Friday, March 4, 2022GENERIC MADRID TRANSACTION CREATED
Saturday, February 12, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, December 14, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 14, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, May 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 5, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 5, 2021REFUSAL PROCESSED BY IB
Thursday, March 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, March 17, 2021REFUSAL PROCESSED BY MPU
Saturday, March 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 12, 2021NON-FINAL ACTION WRITTEN
Friday, February 26, 2021ASSIGNED TO EXAMINER
Friday, December 18, 2020APPLICATION FILING RECEIPT MAILED
Monday, December 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 11, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB